Gastrointestinal Infections News

The FDA has approved the prior approval supplement for Phathom Pharmaceutical’s reformulated vonoprazan tablets for its Voquezna Triple Pak and Voquezna Dual Pak to treat adults with Helicobacter pylori infection, according to a company release.

Vibrio cases and deaths in Florida spiked last year after Hurricane Ian, lending credence to concerns that larger, longer, warmer tropical storms may increase the risk for viral infections, according to a study.

BOSTON — White and Black patients in rural areas face an increased risk for hospital-associated infections, and Black rural patients experience the highest risks for ICU admission an in-hospital death, researchers reported at IDWeek.

BOSTON — The Infectious Diseases Society of America is focused on growing the ID workforce and increasing opportunities for its members, its new president told Healio at IDWeek.

BOSTON — An ongoing outbreak of cholera in Haiti has infected nearly 1 million people, and the situation will not improve unless action is taken, Louise Ivers, MD, MPH, FIDSA, FASTMH, told Healio at IDWeek.

Children who are hospitalized for rotavirus demonstrate a higher risk for developing juvenile-onset autoimmune diseases, including inflammatory arthritis and vasculitis, according to data published in JAMA Network Open.

IDWeek relaxed its COVID-19 policies this year, no longer requiring that attendees wear a mask or provide proof of vaccination.

Researchers confirmed that rat lungworm, or Angiostrongylus cantonensis, has established a presence in Georgia, adding to the states where the invasive parasite has been identified.

The FDA has issued a safety alert warning patients and health care providers of a “risk of invasive, potentially fatal disease” linked to probiotic use among preterm infants in hospital settings.

Nearly half a million Americans are diagnosed with Clostridioides difficile infection each year. Although often treated with antibiotics, C. difficile recurrence is possible. However, recently developed therapies may change this paradigm.